Berobenatide
A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)
Pfizer · Phase 3 · Recruiting · Enrollment 197
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.